These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12055587)

  • 21. Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?
    Fennerty MB
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S30-7. PubMed ID: 12478242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
    Wang F; Lv ZS; Fu YK
    Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma.
    Heeren P; Plukker J; van Dullemen H; Nap R; Hollema H
    Cancer Lett; 2005 Jul; 225(2):283-9. PubMed ID: 15978332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Barrett's esophageal adenocarcinoma].
    Nakamura T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):322-6. PubMed ID: 15045933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
    Prins MJ; Verhage RJ; ten Kate FJ; van Hillegersberg R
    J Gastrointest Surg; 2012 May; 16(5):956-66. PubMed ID: 22258871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus.
    Kaur BS; Khamnehei N; Iravani M; Namburu SS; Lin O; Triadafilopoulos G
    Gastroenterology; 2002 Jul; 123(1):60-7. PubMed ID: 12105834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma.
    Li Y; Wo JM; Ray MB; Jones W; Su RR; Ellis S; Martin RC
    World J Gastroenterol; 2006 Feb; 12(6):928-34. PubMed ID: 16521222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.
    Sivula A; Buskens CJ; van Rees BP; Haglund C; Offerhaus GJ; van Lanschot JJ; Ristimäki A
    Int J Cancer; 2005 Oct; 116(6):903-8. PubMed ID: 15856454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey.
    Ratnasinghe D; Tangrea J; Roth MJ; Dawsey S; Hu N; Anver M; Wang QH; Taylor PR
    Anticancer Res; 1999; 19(1A):171-4. PubMed ID: 10226539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer.
    Ling FC; Baldus SE; Khochfar J; Xi H; Neiss S; Brabender J; Metzger R; Drebber U; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Histopathology; 2007 Jan; 50(2):203-9. PubMed ID: 17222248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus.
    Wilson KT
    Dis Esophagus; 2002; 15(1):16-21. PubMed ID: 12060038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma.
    Uefuji K; Ichikura T; Mochizuki H; Shinomiya N
    J Surg Oncol; 1998 Nov; 69(3):168-72. PubMed ID: 9846504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
    J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
    Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
    Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
    Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression.
    Kawabe A; Shimada Y; Uchida S; Maeda M; Sato F; Itami A; Imamura M
    Oncology; 2002; 62(1):46-54. PubMed ID: 11810043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.